P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYNDROME (CRS) WITH IV VS SUBCUTANEOUS (SC) ALNUCTAMAB (ALNUC; BMS-986349; CC-93269) IN PATIENTS WITH RELAPSED/REFRACTORY MUL...

por Boss, Isaac, Thompson, Ethan, Gaudy, Allison, Vu, Thi Minh Diem, Godwin, Colin, Burgess, Michael, Wong, Sandy W., Costa, Luciano
Publicado 2023

Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T Cells

por Wong, Sandy W., Shah, Nina, Ledergor, Guy, Martin, Thomas, Wolf, Jeffrey, Shui, Amy M., Huang, Chiung-Yu, Martinez-Lopez, Joaquin
Publicado 2021

Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

por Kennedy, Vanessa E., Wong, Christopher, Huang, Chiung-Yu, Kambhampati, Swetha, Wolf, Jeffrey, Martin, Thomas G., Shah, Nina, Wong, Sandy W.
Publicado 2021

DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma

por Choudhry, Priya, Mariano, Margarette C., Geng, Huimin, Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Wiita, Arun P.
Publicado 2019

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy

por Kambhampati, Swetha, Sheng, Ying, Huang, Chiung-Yu, Bylsma, Sophia, Lo, Mimi, Kennedy, Vanessa, Natsuhara, Kelsey, Martin, Thomas, Wolf, Jeffrey, Shah, Nina, Wong, Sandy W.
Publicado 2022

Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation

por Banerjee, Rahul, Lazar, Ann A., Dunn, Lisa, Knoche, Jennifer, Lo, Mimi, Arora, Shagun, Wong, Sandy W., Wolf, Jeffrey L., Martin, Thomas G., Dhruva, Anand, Shah, Nina
Publicado 2021

Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth

por Ma, Xun, Wong, Sandy W., Zhou, Ping, Chaulagain, Chakra P., Doshi, Parul, Klein, Andreas K., Sprague, Kellie, Kugelmass, Adin, Toskic, Denis, Warner, Melissa, Miller, Kenneth B., Lee, Lisa, Varga, Cindy, Comenzo, Raymond L.
Publicado 2018

Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study

por Banerjee, Rahul, Huang, Chiung-Yu, Dunn, Lisa, Knoche, Jennifer, Ryan, Chloe, Brassil, Kelly, Jackson, Lindsey, Patel, Dhiren, Lo, Mimi, Arora, Shagun, Wong, Sandy W, Wolf, Jeffrey, Martin III, Thomas, Dhruva, Anand, Shah, Nina
Publicado 2022

Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies

por Tsang, Mazie, Bischoff, Kara, Schoenbeck, Kelly L., Berry, Kim, O’Riordan, David, Fakhri, Bita, Wong, Sandy W., Shah, Nina, Olin, Rebecca, Andreadis, Charalambos, Vieaux, Jules, Cohen, Eve, Lopez, Nancy Shepard, Mannis, Gabriel N., Rabow, Michael
Publicado 2023

Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment

por Lam, Christine, Ferguson, Ian D., Mariano, Margarette C., Lin, Yu-Hsiu T., Murnane, Megan, Liu, Hui, Smith, Geoffrey A., Wong, Sandy W., Taunton, Jack, Liu, Jun O., Mitsiades, Constantine S., Hann, Byron C., Aftab, Blake T., Wiita, Arun P.
Publicado 2018

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p

por Wong, Sandy W., Hegenbart, Ute, Palladini, Giovanni, Shah, Gunjan L., Landau, Heather J., Warner, Melissa, Toskic, Denis, Jaccard, Arnaud, Hansen, Timon, Bladé, Joan, Cibeira, M. Teresa, Kastritis, Efstathios, Dispenzieri, Angela, Wechalekar, Ashutosh, Varga, Cindy, Schönland, Stefan O., Comenzo, Raymond L.
Publicado 2018

Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma

por Martin, Thomas G., Shah, Nina, Richter, Joshua, Vesole, David H., Wong, Sandy W., Huang, Chiung‐Yu, Madduri, Deepu, Jagannath, Sundar, Siegel, David S., Biran, Noa, Wolf, Jeffrey L., Parekh, Samir, Cho, Hearn J., Munster, Pamela, Richard, Shambavi, Ziti‐Ljajic, Samira, Chari, Ajai
Publicado 2021

P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY

por Tan, Carlyn, Searle, Emma, Anguille, Sébastien, Bhutani, Manisha, Biran, Noa, Boyd, Kevin, Cowan, Andrew, Matous, Jeffrey, Perrot, Aurore, Berdeja, Jesus, Janowski, Wojciech, Popat, Rakesh, Quach, Hang, Schroeder, Mark, Wong, Sandy W, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Touzeau, Cyrille
Publicado 2023

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma

por Martinez-Lopez, Joaquin, Alonso, Rafael, Wong, Sandy W., Rios, Rafael, Shah, Nina, Ruiz-Heredia, Yanira, Sanchez-Pina, Jose Maria, Sanchez, Ricardo, Bahri, Natasha, Zamanillo, Irene, Poza, Maria, Buenache, Natalia, Encinas, Cristina, Juarez, Luis, Miras, Fatima, Collado, Luis, Barrio, Santiago, Martin, Thomas, Cedena, Maria Teresa, Wolf, Jeffrey
Publicado 2021

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma

por Huang, Hector H., Ferguson, Ian D., Thornton, Alexis M., Bastola, Prabhakar, Lam, Christine, Lin, Yu-Hsiu T., Choudhry, Priya, Mariano, Margarette C., Marcoulis, Makeba D., Teo, Chin Fen, Malato, Julia, Phojanakong, Paul J., Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Hann, Byron, Brooks, Angela N., Wiita, Arun P.
Publicado 2020

P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD3 T-CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST...

por Wong, Sandy W., Bar, Noffar, Victoria Mateos, María, Ribas, Paz, Hansson, Markus, Paris, Laura, Hofmeister, Craig, Rodriguez-Otero, Paula, Aranzazu Bermúdez, Maria, Santoro, Armando, Yee, Andrew J., Creignou, Maria, Encinas, Cristina, Cerchione, Claudio, de la Rubia, Javier, Oriol, Albert, Ferstl, Barbara, Besemer, Britta, Chen, Jinjie, Chung, Alexander, Boss, Isaac W., Gaudy, Allison, LI, Shaoyi, Hsu, Kevin, Godwin, Colin, Burgess, Michael R., San-Miguel, Jesús, Jose Costa, Luciano
Publicado 2023

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

por Ferguson, Ian D., Patiño-Escobar, Bonell, Tuomivaara, Sami T., Lin, Yu-Hsiu T., Nix, Matthew A., Leung, Kevin K., Kasap, Corynn, Ramos, Emilio, Nieves Vasquez, Wilson, Talbot, Alexis, Hale, Martina, Naik, Akul, Kishishita, Audrey, Choudhry, Priya, Lopez-Girona, Antonia, Miao, Weili, Wong, Sandy W., Wolf, Jeffrey L., Martin, Thomas G., Shah, Nina, Vandenberg, Scott, Prakash, Sonam, Besse, Lenka, Driessen, Christoph, Posey, Avery D., Mullins, R. Dyche, Eyquem, Justin, Wells, James A., Wiita, Arun P.
Publicado 2022